Management of acute kidney injury in symptomatic multiple myeloma - Sorbonne Université Access content directly
Journal Articles Kidney International Year : 2021

Management of acute kidney injury in symptomatic multiple myeloma

Abstract

Symptomatic multiple myeloma is commonly complicated by acute kidney injury through various mechanisms. The most frequent is the precipitation of monoclonal free light chains with uromodulin in the distal tubules, defining light chain cast nephropathy. Early diagnosis and identification of the cause of acute kidney injury are required for optimizing management and avoiding chronic kidney injury that strongly affects quality of life and patient survival. In light chain cast nephropathy, often manifesting with severe acute kidney injury, renal recovery requires urgent intervention based on vigorous rehydration, correction of precipitating factors, and efficient anti–plasma cell chemotherapy to rapidly reduce the secretion of nephrotoxic free light chains. Currently, the association of the proteasome inhibitor bortezomib with high-dose dexamethasone is the standard regimen in newly diagnosed patients. The addition of another drug such as cyclophosphamide or an immunodulatory agent may improve free light chain response but raises tolerance concerns in frail patients. Further studies are warranted to confirm the role of anti-CD38 monoclonal antibodies, whose efficacy and tolerance have been documented in patients without renal impairment. Despite controversial results from randomized studies, recent data suggest that in patients with light chain cast nephropathy and acute kidney injury requiring dialysis, the combination of chemotherapy with free light chain removal through high-cutoff hemodialysis may increase renal response recovery rates. Kidney biopsy may be helpful in guiding management and assessing renal prognosis that appears to depend on the extent of cast formation and interstitial fibrosis/tubular atrophy. Because of continuous improvement in life expectancy of patients with multiple myeloma, renal transplantation is likely to be increasingly considered in selected candidates.
Fichier principal
Vignette du fichier
S0085253820314058.pdf (4.48 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03915877 , version 1 (22-03-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Frank Bridoux, Nelson Leung, Mohamed Belmouaz, Virginie Royal, Pierre Ronco, et al.. Management of acute kidney injury in symptomatic multiple myeloma. Kidney International, 2021, 99 (3), pp.570-580. ⟨10.1016/j.kint.2020.11.010⟩. ⟨hal-03915877⟩
49 View
499 Download

Altmetric

Share

Gmail Facebook X LinkedIn More